Developer docs
API playgroundTry for free, no card

Search company profiles

Genepharm

Full company profile

uuid000jj8i

Namestring
Genepharm
Websiteurl
genepharm.com
Company typeenum
Private
Founded yearint
1971
Descriptiontext

Genepharm is a privately held Greek pharmaceutical company headquartered in Pallíni, Greece, founded in 1967. According to its stated firmographic description, the company's focus is on the development, manufacturing, and marketing of generic pharmaceuticals, placing it within the European off-patent medicines segment.

The company operates as a vertically integrated generics producer, combining in-house development, manufacturing, and commercial distribution functions. As a generic-pharma manufacturer, its commercial activity depends on regulatory approvals (principally EMA and Greek national authorities), bioequivalence demonstration against reference listed drugs, and an established product portfolio typical of long-tenured generics firms. The input data does not disclose the specific therapeutic areas, molecule count, dosage forms, manufacturing capacity, or facility footprint.

Business model mechanics — pricing, customer mix, channel structure, export presence, and contract terms — are not described in the available data, and the company's website (genepharm.com) returned only a loading/verification page rather than substantive content during data collection. No headcount, revenue, funding history, ownership, management, partnership, or product-launch information is available in the input. As a result, while Genepharm's core function as a Greek generic-pharma developer/manufacturer/marketer is verifiable, any deeper characterization of scale, commercial reach, or competitive position would require primary disclosure that is not present in the supplied material.

Short descriptiontext

Genepharm is a privately held Greek pharmaceutical company, founded in 1967 and headquartered in Pallíni, focused on the development, manufacturing, and marketing of generic pharmaceutical products.

Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersPallíni, Greece
HQ citystring
Pallíni
HQ countrystring
Greece
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
generic pharmaceuticals, pharmaceutical manufacturing, drug development, generic medicines, pharmaceutical marketing
Industry3 codes
PRIMARYHLAIABAA
Small-Molecule Generics (Branded/Unbranded)
SECONDARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)
SECONDARYHLAIABAJ
Generic ANDA/Regulatory Affairs & Submissions
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Generic Pharmaceuticals
Social media profiles1 record
Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Genepharm is focused on the development, manufacturing and marketing of quality generic pharmaceuticals. The company produces off-patent drug formulations for downstream healthcare buyers. Its operations are centered in Pallíni, Greece, where it has been active since 1967.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Generic Pharmaceuticals
CategoryGeneric Pharmaceuticals
No data
Peers10 records
TypeDirect peer
Description

Greek-headquartered generic pharmaceutical developer and manufacturer with a similar vertically integrated generics model serving EU markets, making Pharmathen the closest geographic and product analog to Genepharm.

TypeDirect peer
Description

Greek pharmaceutical manufacturer focused on generics and branded generics, sharing both Genepharm's home market and its development-plus-manufacturing orientation within the EU generics landscape.

TypeBroad incumbent
Description

World's largest generic medicines manufacturer with broad small-molecule generics portfolios across EU markets; relevant as the dominant incumbent shaping competitive dynamics for EU-based generic players like Genepharm.

4Sandoz
TypeBroad incumbent
Description

Novartis-spin-off generics and biosimilars business and one of the largest global generics competitors; comparable to Genepharm in core small-molecule generics and a benchmark for EU generics economics.

TypeBroad incumbent
Description

Formed by the Mylan-Upjohn merger, Viatris is a major global generics and off-patent pharmaceuticals company with deep EU distribution, serving as a broad incumbent peer for an EU-based generics manufacturer.

TypeBroad incumbent
Description

European-focused generics and consumer healthcare company with established small-molecule generics franchises across Germany, CEE, and broader EU — closely comparable to Genepharm on geography and product scope.

TypeRegional player
Description

Slovenian-headquartered generics manufacturer with a Central and Eastern European distribution footprint; comparable to Genepharm as a Central-Southern European vertically integrated generic player.

TypeRegional player
Description

Hungarian pharmaceutical company with a significant generics business across CEE and Western Europe; comparable to Genepharm in operating from a smaller EU country while serving broader European generics markets.

TypeEmerging player
Description

Icelandic-headquartered specialty generics and biosimilars developer; relevant as a smaller EU-rooted player pushing into higher-value generic/biosimilar segments that Genepharm could pursue as an upgrade path.

TypeRegional player
Description

Polish generics manufacturer with broad EU generics presence and vertically integrated operations; comparable to Genepharm as a Central European generic pharma producer competing for the same EU tender and distribution channels.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Genepharm

Generic Pharmaceuticalsgenepharm.com

Genepharm is a privately held Greek pharmaceutical company, founded in 1967 and headquartered in Pallíni, focused on the development, manufacturing, and marketing of generic pharmaceutical products.

What Genepharm does

Genepharm is a privately held Greek pharmaceutical company headquartered in Pallíni, Greece, founded in 1967. According to its stated firmographic description, the company's focus is on the development, manufacturing, and marketing of generic pharmaceuticals, placing it within the European off-patent medicines segment.

The company operates as a vertically integrated generics producer, combining in-house development, manufacturing, and commercial distribution functions. As a generic-pharma manufacturer, its commercial activity depends on regulatory approvals (principally EMA and Greek national authorities), bioequivalence demonstration against reference listed drugs, and an established product portfolio typical of long-tenured generics firms. The input data does not disclose the specific therapeutic areas, molecule count, dosage forms, manufacturing capacity, or facility footprint.

Business model mechanics — pricing, customer mix, channel structure, export presence, and contract terms — are not described in the available data, and the company's website (genepharm.com) returned only a loading/verification page rather than substantive content during data collection. No headcount, revenue, funding history, ownership, management, partnership, or product-launch information is available in the input. As a result, while Genepharm's core function as a Greek generic-pharma developer/manufacturer/marketer is verifiable, any deeper characterization of scale, commercial reach, or competitive position would require primary disclosure that is not present in the supplied material.

Genepharm firmographics

Firmographics
Name
Genepharm
Website
https://genepharm.com
Company type
Private
Founded year
1971
Headcount range
251–500 employees
Short description
Genepharm is a privately held Greek pharmaceutical company, founded in 1967 and headquartered in Pallíni, focused on the development, manufacturing, and marketing of generic pharmaceutical products.
Ownership category
akta.pro rank

Genepharm industry classification

Industry
Product category
Generic Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIABAA
Small-Molecule Generics (Branded/Unbranded)
SECONDARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)
SECONDARYHLAIABAJ
Generic ANDA/Regulatory Affairs & Submissions

Keywords

  • Generic pharmaceuticals
  • Pharmaceutical manufacturing
  • Drug development
  • Generic medicines
  • Pharmaceutical marketing

Where Genepharm is headquartered

Location

Headquarters

HQ city
Pallíni
HQ country
Greece
HQ region
Europe

Markets served

Genepharm business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Genepharm product offering

Product offering

Core offering

Genepharm is focused on the development, manufacturing and marketing of quality generic pharmaceuticals. The company produces off-patent drug formulations for downstream healthcare buyers. Its operations are centered in Pallíni, Greece, where it has been active since 1967.

Differentiator

Problem solved

Functional benefit

Products and services

  • Generic Pharmaceuticals

Companies that use Genepharm

Customer profile

Ideal customer profiles1 record

Genepharm technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Genepharm competitors and assessment

Company assessment

Direct peers

  • Pharmathen: Greek-headquartered generic pharmaceutical developer and manufacturer with a similar vertically integrated generics model serving EU markets, making Pharmathen the closest geographic and product analog to Genepharm.
  • ELPEN Pharmaceutical: Greek pharmaceutical manufacturer focused on generics and branded generics, sharing both Genepharm's home market and its development-plus-manufacturing orientation within the EU generics landscape.

Broad incumbents

  • Teva Pharmaceutical Industries: World's largest generic medicines manufacturer with broad small-molecule generics portfolios across EU markets; relevant as the dominant incumbent shaping competitive dynamics for EU-based generic players like Genepharm.
  • Sandoz: Novartis-spin-off generics and biosimilars business and one of the largest global generics competitors; comparable to Genepharm in core small-molecule generics and a benchmark for EU generics economics.
  • Viatris: Formed by the Mylan-Upjohn merger, Viatris is a major global generics and off-patent pharmaceuticals company with deep EU distribution, serving as a broad incumbent peer for an EU-based generics manufacturer.
  • STADA Arzneimittel: European-focused generics and consumer healthcare company with established small-molecule generics franchises across Germany, CEE, and broader EU — closely comparable to Genepharm on geography and product scope.

Regional players

  • KRKA: Slovenian-headquartered generics manufacturer with a Central and Eastern European distribution footprint; comparable to Genepharm as a Central-Southern European vertically integrated generic player.
  • Gedeon Richter: Hungarian pharmaceutical company with a significant generics business across CEE and Western Europe; comparable to Genepharm in operating from a smaller EU country while serving broader European generics markets.
  • Polpharma: Polish generics manufacturer with broad EU generics presence and vertically integrated operations; comparable to Genepharm as a Central European generic pharma producer competing for the same EU tender and distribution channels.

Emerging players

  • Alvotech: Icelandic-headquartered specialty generics and biosimilars developer; relevant as a smaller EU-rooted player pushing into higher-value generic/biosimilar segments that Genepharm could pursue as an upgrade path.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat4 records

Key risks4 records

Key highlights4 records

Customer concentration

Genepharm social profiles

Digital presence

Genepharm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Genepharm leadership team

Management profile

Number of profiles

Genepharm funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Genepharm M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genepharm

What does Genepharm do?

Genepharm is focused on the development, manufacturing and marketing of quality generic pharmaceuticals. The company produces off-patent drug formulations for downstream healthcare buyers. Its operations are centered in Pallíni, Greece, where it has been active since 1967.

When was Genepharm founded?

Genepharm was founded in 1971. It employs 251 to 500 people.

Where is Genepharm based?

Genepharm is headquartered in Pallíni, Greece, in the Europe region.

Who are Genepharm's main competitors?

Direct peers on record are Pharmathen and ELPEN Pharmaceutical. Broad incumbents are Teva Pharmaceutical Industries, Sandoz, Viatris and STADA Arzneimittel. Regional players are KRKA, Gedeon Richter and Polpharma. Alvotech is listed as an emerging player.

Does Genepharm have an API?

No public API is recorded for Genepharm.

What industry is Genepharm in?

Genepharm's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAA, Small-Molecule Generics (Branded/Unbranded), with a secondary code of HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals